When did Beta Bionics, Inc. Common Stock report Q4 2024 earnings?

Beta Bionics, Inc. Common Stock (BBNX) reported Q4 2024 earnings on March 25, 2025 after market close.

What were Beta Bionics, Inc. Common Stock's Q4 2024 revenue and EPS?

Beta Bionics, Inc. Common Stock reported revenue of $20.4M and diluted EPS of $-1.82 for Q4 2024.

Did Beta Bionics, Inc. Common Stock beat estimates in Q4 2024?

Revenue beat the consensus estimate of $16.1M by $4.3M. EPS missed the consensus estimate of $-0.42 by $1.40.

Where can I find Beta Bionics, Inc. Common Stock's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-044516) directly on SEC EDGAR. The filing index links above go to sec.gov.

Beta Bionics, Inc. Common Stock BBNX Q4 2024 Annual earnings

Reported March 25, 2025 · After market close

Revenue$20.4MBeat by $4.3M Diluted EPS-$1.82Miss by $1.40

Revenue estimate$16.1M

EPS estimate-$0.42

Next report

Aug 4, 2026 (in a month)

Revenue estimate$31.5M

EPS estimate-$0.62

Financials

Q4 2024

Income statement

See full

Revenue$20.4M+582%

Gross profit$11.7M+641%

Operating income-$13.0M-45.5%

Net income-$18.1M-64.2%

EPS (diluted)-$2.74-31.9%

Balance sheet

See full

Cash & equivalents$30.4M+14.6%

Total debt$7.3M+71.8%

Total equity-$245.4M-20.8%

Total assets$149.6M+36.0%

Cash flow

See full

Operating cash flow-$14.3M-76.0%

CapEx$561.0K+458%

Free cash flow-$14.8M-80.7%

Valuation & ratios

Profitability

See full

Gross margin55.1%+2.5pp

Operating margin-69.5%-30.2pp

Net margin-84.1%-36.6pp

FCF margin-79.3%-32.9pp

Returns & leverage

See full

Current ratio6.3×-3.5×

Segments

By product

See full

I Let$13.5M+431%

Single Use Products$4.4M+1,531%

By geography

See full

Non Us-—

Versus estimates

Revenue

Q1 2026$27.6MBeat by $678.2K Q4 2025$32.1MBeat by $1.7M Q3 2025$27.3MMiss by $1.7M Q2 2025$23.2MBeat by $1.3M Q1 2025$17.6MMiss by $2.0M

Q4 2024$20.4MBeat by $4.3M

Diluted EPS

Q1 2026-$0.49Beat by $0.04 Q4 2025-$0.30Beat by $0.12 Q3 2025-$0.33Beat by $0.12 Q2 2025-$0.39Beat by $0.12 Q1 2025-$0.52Miss by $0.01

Q4 2024-$1.82Miss by $1.40

Ask the moment Beta Bionics, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Beta Bionics, Inc. Common Stock report Q4 2024 earnings?: Beta Bionics, Inc. Common Stock (BBNX) reported Q4 2024 earnings on March 25, 2025 after market close.
What were Beta Bionics, Inc. Common Stock's Q4 2024 revenue and EPS?: Beta Bionics, Inc. Common Stock reported revenue of $20.4M and diluted EPS of $-1.82 for Q4 2024.
Did Beta Bionics, Inc. Common Stock beat estimates in Q4 2024?: Revenue beat the consensus estimate of $16.1M by $4.3M. EPS missed the consensus estimate of $-0.42 by $1.40.
Where can I find Beta Bionics, Inc. Common Stock's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-044516) directly on SEC EDGAR. The filing index links above go to sec.gov.